Effect of fulvine on pulmonary arteries and veins of the rat.
D000284:Administration, Oral; D000818:Animals; D003250:Constriction; D004417:Dyspnea / Q000139:chemically induced; D005260:Female; D005337:Fibrin / Q000032:analysis; D006128:Growth / Q000187:drug effects; D006352:Heart Ventricles / Q000473:pathology; D006470:Hemorrhage / Q000139:chemically induced; D006984:Hypertrophy; D002479:Inclusion Bodies; D007274:Injections, Intraperitoneal; D007501:Iron / Q000032:analysis; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008214:Lymphocytes; D008407:Mast Cells; D009130:Muscle, Smooth / Q000473:pathology; D009929:Organ Size; D011651:Pulmonary Artery / Q000187:drug effects*; D011654:Pulmonary Edema / Q000139:chemically induced; D011667:Pulmonary Veins / Q000187:drug effects*; D011763:Pyrrolizidine Alkaloids / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D011763:Pyrrolizidine Alkaloids; D005337:Fibrin; D007501:Iron